Author information from the last article
Avdeling for rettsmedisinske fag
Oslo universitetssykehus
Forfatterbidrag: tolking av data og revisjon av manus.
Merete S. Vevelstad er ph.d., spesialist i klinisk farmakologi og overlege.
Articles by Merete S. Vevelstad
Deaths associated with MDMA in the period 2000–2019
- Ragnhild E. G. Jamt,
- Hilde M. E. Edvardsen,
- Gerrit Middelkoop,
- Anna S. Kallevik,
- Stig T. Bogstrand,
- Merete S. Vevelstad,
- Vigdis Vindenes
19.05.2022:
MDMA (3,4-methylenedioxymethamphetamine), also known as ecstasy, has been used as a recreational drug since the 1980s. Ecstasy can also contain other, related compounds (1). Its use in Norway peaked in around 2000 (2), and there were reports of numerous deaths and potentially long-term neurotoxic...
Novel psychoactive substances
- Hege M. Krabseth,
- Silja S. Tuv,
- Maren Cecilie Strand,
- Ritva A. Karinen,
- Elisabeth Wiik,
- Merete S. Vevelstad,
- Andreas Austgulen Westin,
- Elisabeth L. Øiestad,
- Vigdis Vindenes
03.05.2016:
There has been a major increase in the number of new drugs of abuse on the global illicit drugs market, including in Norway. These substances are referred to as «novel psychoactive substances» (NPS), and are mainly sold over the Internet. Potent substances in uncertain doses entail a risk of...
New designer drugs from the web
- Silja S. Tuv,
- Hege M. Krabseth,
- Maren Cecilie Strand,
- Ritva A. Karinen,
- Elisabeth Wiik,
- Merete S. Vevelstad,
- Andreas Austgulen Westin,
- Elisabeth L. Øiestad,
- Vigdis Vindenes
03.05.2016:
The illicit drugs market has changed in recent years, and the Internet has become increasingly important as a distribution channel. During the first six months of 2015, more than 200 000 user doses of novel psychoactive substances (NPS) were impounded in Norway. Many of these substances are toxic...